Fluarix (trivalent inactivated “split virus” influenza vaccine [Types A and B], from GlaxoSmithKline) has been approved for use in children 3–17 years of age. This approval was based on data from a ...
Background: The trivalent inactivated split-influenza vaccine, Fluarix TM has been available since 1992. Aim: To assess the safety and immunogenicity of the vaccine from studies in healthy adults and ...
Fluarix Quadrivalent achieved noninferiority to both TIVs based on adjusted GMTs and seroconversion rates. The antibody response to influenza B strains contained in Fluarix Quadrivalent was higher ...
U.S. health regulators have approved a new four-strain seasonal influenza vaccine made by GlaxoSmithKline Plc, the company said on Monday. The U.S. Food and Drug Administration has approved Fluarix ...
Sept. 1, 2005 — The U.S. Food and Drug Administration (FDA) has approved a trivalent inactivated split influenza vaccine for the prophylaxis of influenza types A and B in adults; mecasermin [rDNA ...
As a severe flu season continues to unfold in the U.S., GlaxoSmithKline is touting phase 3 study data showing its Fluarix Tetra can protect young children who are among the most vulnerable to the ...
PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in preparation for ...
With the books closed on 2012, we can confirm--as expected--that a majority of the major FDA vaccine approvals went to trivalent influenza vaccines. (The FDA is continuing this trend with the first ...
Strong HA-specific antibody responses were observed in all groups immunized with Fluarix® Tetra, whether co-administered with OVX836 or as a stand-alone, with similar HAI titers across all four ...
GlaxoSmithKline says it had filed its flu vaccine, Fluarix, with the US Food and Drug Administration. The firm is clearly hoping to carve a niche for itself in the US flu vaccines market after the ...
The Food and Drug Administration (FDA) today approved Fluarix, an influenza vaccine for adults that contains inactivated virus. Fluarix is approved to immunize adults 18 years of age and older against ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...